|
1
|
Patel V: Cultural factors and
international epidemiology. Br Med Bull. 57:33–45. 2001.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lépine JP and Briley M: The increasing
burden of depression. Neuropsychiatr Dis Treat. 7 (Suppl 1):S3–S7.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang F and Pereira A: Neuromodulation,
emotional feelings and affective disorders. Mens Sana Monogr.
14:5–29. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Slavich GM and Irwin MR: From stress to
inflammation and major depressive disorder: A social signal
transduction theory of depression. Psychol Bull. 140:774–815.
2014.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Lindqvist D, Dhabhar FS, James SJ, Hough
CM, Jain FA, Bersani FS, Reus VI, Verhoeven JE, Epel ES, Mahan L,
et al: Oxidative stress, inflammation and treatment response in
major depression. Psychoneuroendocrinology. 76:197–205.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Anisman H, Merali Z and Hayley S:
Neurotransmitter, peptide and cytokine processes in relation to
depressive disorder: Comorbidity between depression and
neurodegenerative disorders. Prog Neurobiol. 85:1–74.
2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sarris J, Murphy J, Mischoulon D,
Papakostas GI, Fava M, Berk M and Ng CH: Adjunctive nutraceuticals
for depression: A systematic review and meta-analyses. Am J
Psychiatry. 173:575–587. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Behr GA, Moreira JC and Frey BN:
Preclinical and clinical evidence of antioxidant effects of
antidepressant agents: Implications for the pathophysiology of
major depressive disorder. Oxid Med Cell Longev.
2012(609421)2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ni CX, Gong H, Liu Y, Qi Y, Jiang CL and
Zhang JP: Green tea consumption and the risk of liver cancer: A
meta-analysis. Nutr Cancer. 69:211–220. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Syed Hussein SS, Kamarudin MN and Kadir
HA: (+)-catechin attenuates NF-κB activation through regulation of
Akt, MAPK, and AMPK signaling pathways in LPS-induced BV-2
microglial cells. Am J Chin Med. 43:927–952. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhu BT, Shim JY, Nagai M and Bai HW:
Molecular modelling study of the mechanism of high-potency
inhibition of human catechol-O-methyltransferase by
(-)-epigallocatechin-3-O-gallate. Xenobiotica. 38:130–146.
2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rai A, Das S, Chamallamudi MR, Nandakumar
K, Shetty R, Gill M, Sumalatha S, Devkar R, Gourishetti K and Kumar
N: Evaluation of the aphrodisiac potential of a chemically
characterized aqueous extract of Tamarindus indica pulp. J
Ethnopharmacol. 210:118–124. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lee B, Sur B, Kwon S, Yeom M, Shim I, Lee
H and Hahm DH: Chronic administration of catechin decreases
depression and anxiety-like behaviors in a rat model using chronic
corticosterone injections. Biomol Ther (Seoul). 21:313–322.
2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gill M, Kinra M, Rai A, Chamallamudi MR
and Kumar N: Evaluation of antidepressant activity of methanolic
extract of Saraca asoca bark in a chronic unpredictable mild stress
model. Neuroreport. 29:134–140. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ministry of Environment and Forests and
Climate Change Government of India: Compendium of CPCSEA 2018.
Committee for the Purpose of Control and Supervision of Experiments
on Animals (CPCSEA), New Delhi, 2018. http://cpcsea.nic.in/WriteReadData/userfiles/file/Compendium%20of%20CPCSEA.pdf.
|
|
16
|
Zanwar AA, Badole SL, Shende PS, Hegde MV
and Bodhankar SL: Chapter 21 - Antioxidant role of catechin in
health and disease. In: Polyphenols in human health and disease.
Watson RR, Preedy VR and Zibadi S (eds.) Academic Press, San Diego,
CA. pp267–271. 2014. View Article : Google Scholar
|
|
17
|
Castagné V, Porsolt RD and Moser P: Use of
latency to immobility improves detection of antidepressant-like
activity in the behavioral despair test in the mouse. Eur J
Pharmacol. 616:128–133. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kumar N, Choudhary A, Tiwari A, Rasal A,
Jetti R and Rao CM: Evaluation of hepatoprotective effect of
aqueous extract of Schrebera swietenioides Bark against
carbon tetrachloride-induced toxicity in wistar rats. Advanced Sci
Lett. 23:1917–1920. 2017. View Article : Google Scholar
|
|
19
|
Kumar N, Rai A, Reddy ND, Shenoy RR,
Mudgal J, Bansal P, Mudgal PP, Arumugam K, Udupa N, Sharma N and
Rao CM: Improved in vitro and in vivo hepatoprotective effects of
liposomal silymarin in alcohol-induced hepatotoxicity in Wistar
rats. Pharmacol Rep. (In Press). View Article : Google Scholar
|
|
20
|
Luo DD, An SC and Zhang X: Involvement of
hippocampal serotonin and neuropeptide Y in depression induced by
chronic unpredicted mild stress. Brain Res Bull. 77:8–12.
2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cheruku S, Chamallamudi M, Ramalingayya G,
Biswas S, Gourishetti K, Nandakumar K, Devkar R, Mallik SB,
Nampoothiri M and Kumar N: Neuroprotective potential of methanolic
extract of Saraca asoca bark against doxorubicin-induced
neurotoxicity. Pharmacog Mag. 15:309–316. 2019. View Article : Google Scholar
|
|
22
|
Vaváková M, Ďuračková Z and Trebatická J:
Markers of oxidative stress and neuroprogression in depression
disorder. Oxid Med Cell Longev. 2015(898393)2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Thakare VN, Patil RR, Oswal RJ, Dhakane
VD, Aswar MK and Patel BM: Therapeutic potential of silymarin in
chronic unpredictable mild stress induced depressive-like behavior
in mice. J Psychopharmacol. 32:223–235. 2018.PubMed/NCBI View Article : Google Scholar
|
